Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:filgrastim
|
| gptkbp:affiliatedWith |
colony stimulating factors
|
| gptkbp:approvedBy |
gptkb:Australia
gptkb:European_Union 2010 |
| gptkbp:ATCCode |
L03AA02
|
| gptkbp:contraindication |
hypersensitivity to filgrastim
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nivestim
|
| gptkbp:indication |
bone marrow transplantation
chronic neutropenia peripheral blood progenitor cell mobilization |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
stimulates production of neutrophils
|
| gptkbp:routeOfAdministration |
intravenous infusion
subcutaneous injection |
| gptkbp:sideEffect |
nausea
headache bone pain musculoskeletal pain |
| gptkbp:storage |
2-8°C
|
| gptkbp:type |
biosimilar
|
| gptkbp:usedFor |
neutropenia
chemotherapy-induced neutropenia |
| gptkbp:bfsParent |
gptkb:filgrastim
|
| gptkbp:bfsLayer |
8
|